Registered lobbyist

Lisa Langenderfer

The register gives a lobbyist a separate record at each firm. This person is very likely also listed as Lisa Langenderfer (Astrazeneca Pharmaceuticals Lp), with the same distinctive name at back-to-back firms. The register itself does not confirm these are one person.

Lobby filings
34
Clients
1
Firms
1
Total contributed
$1,104
Contributions
4
Committees
2
Contribution reports
15

Lobby filings counts every filing that names this lobbyist, amendments included. Contributions come from the twice-yearly LD-203 reports, counting the current version of each report once.

Lobbying filings

34 filings, newest first.
FilingFirmClientAmount
3rd Quarter - Report
3rd Quarter 2024
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $640,000 reported
2nd Quarter - Report
2nd Quarter 2024
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $650,000 reported
1st Quarter - Report
1st Quarter 2024
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $1,580,000 reported
4th Quarter - Report
4th Quarter 2023
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $720,000 reported
3rd Quarter - Report
3rd Quarter 2023
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $530,000 reported
1st Quarter - Amendment
1st Quarter 2023
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $1,230,000 reported
2nd Quarter - Report
2nd Quarter 2023
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $510,000 reported
1st Quarter - Reportreplaced
1st Quarter 2023
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $440,000 reported
4th Quarter - Amendment
4th Quarter 2022
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $810,000 reported
4th Quarter - Reportreplaced
4th Quarter 2022
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY $440,000 reported

Political contributions

4 contributions, newest first.
Recipient or honoreePayeeDateAmount
Jodey Arrington Paid to TEXANS FOR JODEY ARRINGTON Sep 18, 2023 $500
The US Oncology Network PAC Paid to THE US ONCOLOGY NETWORK PAC Dec 31, 2019 $250
The US Oncology Network PAC Paid to THE US ONCOLOGY NETWORK PAC Jun 30, 2019 $250
The US Oncology Network PAC Paid to THE US ONCOLOGY NETWORK PAC Dec 31, 2018 $104

Committees given to most

The payees on this lobbyist's current reports, by total given. The payee is stated on the report; the legislator behind a committee is not.

PayeeContributionsTotal
THE US ONCOLOGY NETWORK PAC 3 $604
TEXANS FOR JODEY ARRINGTON 1 $500

Contribution reports (LD-203)

Every report the register holds. A report replaced by a later version is listed but not counted.

PeriodFiledCountedOfficial report
Mid Year 2024, no contributions Jul 19, 2024 Yes Open
Year End 2023 Jan 22, 2024 Yes Open
Mid Year 2023, no contributions Jul 19, 2023 Yes Open
Year End 2022, no contributions Jan 30, 2023 Yes Open
Mid Year 2022, no contributions Jul 14, 2022 Yes Open
Mid Year 2022, no contributions Jul 14, 2022 Replaced Open
Year End 2021, no contributions Jan 28, 2022 Yes Open
Mid Year 2021, no contributions Oct 6, 2021 Yes Open
Year End 2020, no contributions Feb 16, 2021 Yes Open
Mid Year 2020, no contributions Sep 16, 2020 Yes Open
Year End 2019 Jan 22, 2020 Yes Open
Mid Year 2019 Jul 30, 2019 Yes Open
Year End 2018 Jan 30, 2019 Yes Open
Mid Year 2018, no contributions Jul 23, 2018 Yes Open
Year End 2017, no contributions Jan 30, 2018 Yes Open

From reports filed under the Lobbying Disclosure Act: LD-2 reports name the lobbyists who worked on each issue, and LD-203 reports list their political contributions twice a year.